z-logo
open-access-imgOpen Access
Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in the Treatment of Patients with Advanced Primary Hepatocellular Carcinoma: A Retrospective, Real-World Study in China
Author(s) -
Xiao-Qi Chen,
Yun-Xia Zhao,
Chuanlei Zhang,
Xinting Wang,
Xin Zhang,
Xi Chen,
Chang-Wei Yuan,
Qing Zhao,
Xinju Chen
Publication year - 2022
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s358092
Subject(s) - medicine , clinical endpoint , hepatocellular carcinoma , retrospective cohort study , gastroenterology , adverse effect , oncology , surgery , clinical trial

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom